Your Messages Inbox
Your Article Summary
See Latest ArticlesAbbott to Acquire Solvay Pharmaceuticals Business
Abbott, 09/29/09
Abbott today announced a definitive agreement with the Solvay Group for Abbott to acquire Solvay's pharmaceuticals business for EUR 4.5 billion in cash, providing Abbott with a large and complementary portfolio of pharmaceutical products and a significant presence in key global emerging markets. The acquisition also includes full global rights to the fenofibrate franchise. Currently Abbott has U.S. rights to fenofibrate and pays royalties to Solvay.
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Visanne cleared for market launch in Europe as new treatment option for endometriosis
BayNews International, 12/08/09
Bristol-Myers Squibb and Mead Johnson Announce Amendment and Extension of Exchange Offer
Bristol Myers-Squibb Company, 12/07/09
Prodesses ProParaflu+(TM) Assay Cleared for US Marketing by FDA
Gen-Probe, 12/03/09
Article Search
Sponsor